| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |